BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21087097)

  • 1. Interleukin-32 gamma specific monoclonal antibody and developing IL-32 specific ELISA.
    Lee S; Kim S; Bae S; Choi J; Hong J; Ryoo S; Jhun H; Hong K; Kim E; Jo S; Her E; Kim S
    Hybridoma (Larchmt); 2010 Dec; 29(6):501-9. PubMed ID: 21087097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA.
    Kim KH; Shim JH; Seo EH; Cho MC; Kang JW; Kim SH; Yu DY; Song EY; Lee HG; Sohn JH; Kim J; Dinarello CA; Yoon DY
    J Immunol Methods; 2008 Apr; 333(1-2):38-50. PubMed ID: 18252253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-32γ overexpression accelerates streptozotocin (STZ)-induced type 1 diabetes.
    Jhun H; Choi J; Hong J; Lee S; Kwak A; Kim E; Jo S; Ryoo S; Lim Y; Yoon DY; Hong JT; Kim TS; Lee Y; Song K; Kim S
    Cytokine; 2014 Sep; 69(1):1-5. PubMed ID: 25022955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection.
    Bae S; Kang D; Hong J; Chung B; Choi J; Jhun H; Hong K; Kim E; Jo S; Lee S; Kim SH; Kim S
    Cytokine; 2012 Apr; 58(1):79-86. PubMed ID: 22277801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the most active interleukin-32 isoform.
    Choi JD; Bae SY; Hong JW; Azam T; Dinarello CA; Her E; Choi WS; Kim BK; Lee CK; Yoon DY; Kim SJ; Kim SH
    Immunology; 2009 Apr; 126(4):535-42. PubMed ID: 18771438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis.
    Heinhuis B; Koenders MI; van de Loo FA; Netea MG; van den Berg WB; Joosten LA
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4962-7. PubMed ID: 21383200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-32γ transgenic mice resist LPS-mediated septic shock.
    Kim SJ; Lee S; Kwak A; Kim E; Jo S; Bae S; Lee Y; Ryoo S; Choi J; Kim S
    J Microbiol Biotechnol; 2014 Aug; 24(8):1133-42. PubMed ID: 24743568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production.
    Jung MY; Son MH; Kim SH; Cho D; Kim TS
    J Immunol; 2011 Jun; 186(12):6848-59. PubMed ID: 21551364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of isoform-specific monoclonal antibodies against human IL-18 binding protein.
    Lee S; Kim S; Bae S; Choi J; Hong J; Ryoo S; Jhun H; Hong K; Kim E; Jo S; Her E; Kim S
    Hybridoma (Larchmt); 2010 Dec; 29(6):517-24. PubMed ID: 21087098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-32γ suppresses allergic airway inflammation in mouse models of asthma.
    Bang BR; Kwon HS; Kim SH; Yoon SY; Choi JD; Hong GH; Park S; Kim TB; Moon HB; Cho YS
    Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1021-30. PubMed ID: 24328857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection.
    Li W; Sun W; Liu L; Yang F; Li Y; Chen Y; Fang J; Zhang W; Wu J; Zhu Y
    J Immunol; 2010 Nov; 185(9):5056-65. PubMed ID: 20889550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-32γ induces chemotaxis of activated T cells via dendritic cell-derived CCL5.
    Son MH; Jung MY; Choi S; Cho D; Kim TS
    Biochem Biophys Res Commun; 2014 Jul; 450(1):30-5. PubMed ID: 24882804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-32γ enhances TNF-α-induced cell death in colon cancer.
    Park ES; Yoo JM; Yoo HS; Yoon DY; Yun YP; Hong J
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E23-35. PubMed ID: 23255489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of polyclonal and monoclonal antibodies for immunoassay and neutralization of human interleukin-4.
    Chrétien I; Van Kimmenade A; Pearce MK; Banchereau J; Abrams JS
    J Immunol Methods; 1989 Feb; 117(1):67-81. PubMed ID: 2643668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.
    Matsuda T; Hirano T; Kishimoto T
    Eur J Immunol; 1988 Jun; 18(6):951-6. PubMed ID: 3260187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-32gamma and Streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2.
    Heinhuis B; Koenders MI; van de Loo FA; van Lent PL; Kim SH; Dinarello CA; Joosten LA; van den Berg WB
    Ann Rheum Dis; 2010 Oct; 69(10):1866-72. PubMed ID: 20472585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.
    Johansen C; Vinter H; Soegaard-Madsen L; Olsen LR; Steiniche T; Iversen L; Kragballe K
    Br J Dermatol; 2010 Dec; 163(6):1194-204. PubMed ID: 20846304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-32, a novel cytokine with a possible role in disease.
    Dinarello CA; Kim SH
    Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii61-4. PubMed ID: 17038476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of rat anti-mouse ST2L monoclonal antibodies.
    Fursov N; Johnston E; Duffy K; Cotty A; Petley T; Fisher J; Jiang H; Rycyzyn MA; Giles-Komar J; Powers G
    Hybridoma (Larchmt); 2011 Apr; 30(2):153-62. PubMed ID: 21529288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an interleukin (IL)-33 sandwich ELISA kit specific for mature IL-33.
    Kim E; Kwak A; Jhun H; Lee S; Jo S; Lee J; Kang TB; Her E; Bae S; Lee Y; Kim S
    J Immunoassay Immunochem; 2016; 37(6):585-96. PubMed ID: 27092422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.